CUE
Cue Biopharma
25.30$
-2.4%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +122.5% | +311.3% | -32.2% | +57.8% | +39.0% | -16.2% | +9.5% | -32.6% | -47.7% | +31.1% | |
| – | +132.7% | +329.8% | -37.6% | +50.3% | +43.4% | -21.8% | +12.7% | -33.3% | -51.1% | +47.1% | |
| – | +133.0% | +325.7% | -67.3% | +112.9% | +69.0% | -14.0% | -19.8% | -6.0% | -53.7% | +20.8% | |
| – | +132.0% | +324.6% | -38.3% | +51.5% | +42.9% | -24.2% | +18.5% | -36.4% | -53.7% | +20.8% | |
| – | – | – | – | – | +87.8% | +121.7% | -98.2% | +2,878.9% | -44.3% | +687.8% | |
| – | – | – | – | – | – | – | +0.0% | +0.0% | – | – | |
| – | +44.2% | +65.2% | +64.5% | +158.3% | -70.7% | +0.2% | -29.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | +193.4% | +384.3% | +113.1% | +49.4% | +21.2% | -13.2% | +43.0% | -4.5% | -39.9% | +7.4% | |
| – | +212.0% | +400.8% | +16.3% | +87.5% | +40.0% | -21.6% | -9.7% | +47.9% | -19.9% | -1.4% | |
| – | – | – | – | – | +7.4% | +44.4% | -23.7% | +39.3% | +7.4% | -75.7% | |
| – | +275.1% | +153.7% | +53.1% | -56.6% | +134.6% | +25.1% | +5.4% | +28.2% | -19.4% | +39.9% | |
| – | – | – | – | – | – | – | – | -47.7% | – | – | |
| – | +118.7% | +306.0% | -44.9% | +60.7% | +44.6% | -17.0% | +0.3% | -43.5% | -52.8% | +51.0% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | +180.7% | +0.0% | -2.5% | +9.5% | +30.2% | +9.1% | +13.9% | +28.3% | +23.1% | +68.2% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.